tiprankstipranks
Trending News
More News >

Arecor Therapeutics to Announce 2024 Financial Results

Story Highlights
  • Arecor Therapeutics focuses on enhancing existing therapies using its Arestat™ platform.
  • The company will release its 2024 financial results on 22 April 2025, with a briefing for analysts.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Arecor Therapeutics to Announce 2024 Financial Results

Elevate Your Investing Strategy:

Arecor Therapeutics PLC ( (GB:AREC) ) has shared an announcement.

Arecor Therapeutics plc announced it will release its audited final results for the year ended 31 December 2024 on 22 April 2025. The announcement will include an in-person briefing for analysts, along with a live webcast and conference call, indicating the company’s commitment to transparency and engagement with stakeholders.

More about Arecor Therapeutics PLC

Arecor Therapeutics plc is a biopharmaceutical company focused on transforming patient care by bringing innovative medicines to market. Utilizing its proprietary technology platform, Arestat™, Arecor enhances existing therapeutic products and develops a portfolio of proprietary products in diabetes and other areas. The company collaborates with leading pharmaceutical and biotechnology firms to deliver therapeutic solutions.

YTD Price Performance: -48.30%

Average Trading Volume: 17,219

Technical Sentiment Signal: Strong Buy

Current Market Cap: £14.35M

For detailed information about AREC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1